Cell-Free Proteins
Protein-based drugs are a fast-growing class of new medicines, but they cost 20 to 100 times more to make than conventional drugs. One reason is that proteins can only be made by living cells, which are not very efficient producers. Researchers at Stanford University believe they can cut costs by doing away with the cells and instead exploiting the protein-making machinery inside them. Chemical engineer Jim Swartz and his colleagues have come up with a way of growing bacteria, busting them open, pulling out their innards, and adding a soup of chemicals that mimics the inside of a cell. Also tossed into the mix are amino acids (proteins’ building blocks), enzymes, and strands of DNA that encode the protein to be churned out. With no cells to keep alive, all those parameters can be fine-tuned for protein production. Swartz says the method can boost protein production five- to 10-fold and cut up to 80 percent of the capital costs. The researchers founded Fundamental Applied Biology in San Francisco, CA, to commercialize the technique.
Other Prototypes:
Videoconferencing by the Numbers
Keep Reading
Most Popular
Geoffrey Hinton tells us why he’s now scared of the tech he helped build
“I have suddenly switched my views on whether these things are going to be more intelligent than us.”
ChatGPT is going to change education, not destroy it
The narrative around cheating students doesn’t tell the whole story. Meet the teachers who think generative AI could actually make learning better.
Meet the people who use Notion to plan their whole lives
The workplace tool’s appeal extends far beyond organizing work projects. Many users find it’s just as useful for managing their free time.
Learning to code isn’t enough
Historically, learn-to-code efforts have provided opportunities for the few, but new efforts are aiming to be inclusive.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.